969 related articles for article (PubMed ID: 19406869)
21. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
[TBL] [Abstract][Full Text] [Related]
22. [Myocardial disease mortality in children and young adults. A population-based observational study].
Morentin B; Suárez-Mier MP; Aguilera B; Bodegas A
Rev Esp Cardiol; 2006 Mar; 59(3):238-46. PubMed ID: 16712748
[TBL] [Abstract][Full Text] [Related]
23. The pathology of hypertrophic cardiomyopathy.
Hughes SE
Histopathology; 2004 May; 44(5):412-27. PubMed ID: 15139989
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
O'Hanlon R; Grasso A; Roughton M; Moon JC; Clark S; Wage R; Webb J; Kulkarni M; Dawson D; Sulaibeekh L; Chandrasekaran B; Bucciarelli-Ducci C; Pasquale F; Cowie MR; McKenna WJ; Sheppard MN; Elliott PM; Pennell DJ; Prasad SK
J Am Coll Cardiol; 2010 Sep; 56(11):867-74. PubMed ID: 20688032
[TBL] [Abstract][Full Text] [Related]
25. Sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ; Fananapazir L
Circulation; 1992 Jan; 85(1 Suppl):I57-63. PubMed ID: 1728506
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
[TBL] [Abstract][Full Text] [Related]
27. Morphologic features of exertional versus nonexertional sudden death in patients with hypertrophic cardiomyopathy.
Tavora F; Cresswell N; Li L; Ripple M; Fowler D; Burke A
Am J Cardiol; 2010 Feb; 105(4):532-7. PubMed ID: 20152250
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy.
Wang SX; Fu CY; Zou YB; Wang H; Shi Y; Xu XQ; Chen JZ; Song XD; Huan TJ; Hui RT
Chin Med J (Engl); 2008 Jan; 121(1):27-31. PubMed ID: 18208662
[TBL] [Abstract][Full Text] [Related]
29. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P
J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
[TBL] [Abstract][Full Text] [Related]
30. Risk of sudden death in end-stage hypertrophic cardiomyopathy.
Kawarai H; Kajimoto K; Minami Y; Hagiwara N; Kasanuki H
J Card Fail; 2011 Jun; 17(6):459-64. PubMed ID: 21624733
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
[TBL] [Abstract][Full Text] [Related]
32. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
Maron BJ; Rowin EJ; Casey SA; Haas TS; Chan RH; Udelson JE; Garberich RF; Lesser JR; Appelbaum E; Manning WJ; Maron MS
Circulation; 2013 Feb; 127(5):585-93. PubMed ID: 23275385
[TBL] [Abstract][Full Text] [Related]
33. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.
Christiaans I; Birnie E; van Langen IM; van Spaendonck-Zwarts KY; van Tintelen JP; van den Berg MP; Atsma DE; Helderman-van den Enden AT; Pinto YM; Hermans-van Ast JF; Bonsel GJ; Wilde AA
Eur Heart J; 2010 Apr; 31(7):842-8. PubMed ID: 20019025
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy.
Leonardi S; Raineri C; De Ferrari GM; Ghio S; Scelsi L; Pasotti M; Tagliani M; Valentini A; Dore R; Raisaro A; Arbustini E
Eur Heart J; 2009 Aug; 30(16):2003-10. PubMed ID: 19474054
[TBL] [Abstract][Full Text] [Related]
35. Morphological changes associated with hemodynamically significant myocardial bridges in sudden cardiac death.
Hostiuc S; Curca GC; Dermengiu D; Dermengiu S; Hostiuc M; Rusu MC
Thorac Cardiovasc Surg; 2011 Oct; 59(7):393-8. PubMed ID: 21448858
[TBL] [Abstract][Full Text] [Related]
36. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death.
Fabre A; Sheppard MN
Heart; 2006 Mar; 92(3):316-20. PubMed ID: 15923280
[TBL] [Abstract][Full Text] [Related]
37. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
Maron MS; Zenovich AG; Casey SA; Link MS; Udelson JE; Aeppli DM; Maron BJ
Am J Cardiol; 2005 Jun; 95(11):1329-33. PubMed ID: 15904638
[TBL] [Abstract][Full Text] [Related]
38. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
[TBL] [Abstract][Full Text] [Related]
39. Hypertrophic cardiomyopathy: case report.
Mukhtar AU; Ihunwo AO
East Afr Med J; 1999 Sep; 76(9):535-6. PubMed ID: 10685328
[TBL] [Abstract][Full Text] [Related]
40. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.
Basso C; Thiene G; Corrado D; Buja G; Melacini P; Nava A
Hum Pathol; 2000 Aug; 31(8):988-98. PubMed ID: 10987261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
